Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May;4(1):50-53.
doi: 10.15420/cfr.2018:9:1.

Identification and Treatment of Central Sleep Apnoea: Beyond SERVE-HF

Affiliations
Review

Identification and Treatment of Central Sleep Apnoea: Beyond SERVE-HF

William T Abraham et al. Card Fail Rev. 2018 May.

Abstract

Central sleep apnoea (CSA) occurs in a large proportion of HF patients. CSA has clear detrimental effects, resulting in intermittent hypoxia and sympathetic activation, and is associated with significant morbidity and mortality. Treatment options are limited following the results of a recent trial in which adaptive servo-ventilation resulted in an increase in cardiovascular mortality. Ongoing studies utilising other forms of positive airway pressure may provide additional insight into the results of this trial. A new neurostimulation therapy, phrenic nerve stimulation, has offered a new physiological approach to the treatment of CSA. This therapy has resulted in improvements in the severity of disease and quality of life.

Keywords: Central sleep apnoea; heart failure; hypoxia; phrenic nerve stimulation.

PubMed Disclaimer

Conflict of interest statement

Disclosure: WA is a consultant to Respicardia (manufacturer of the phrenic nerve stimulation device discussed); RG is Chief Medical Officer of Respicardia; AP has no conflicts to disclose.

Figures

Figure 1:
Figure 1:. Example of Central Sleep Apnea with Cheyne-Stokes Respiration
Figure 2:
Figure 2:. Interaction of Heart Failure (HF) and Central Sleep Apnoea (CSA)

References

    1. Oldenburg O, Lamp B, Faber L et al. Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail. 2007;9:251–7. doi: 10.1016/j.ejheart.2006.08.003. - DOI - PubMed
    1. Khayat R, Abraham W, Patt B et al. Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure. J Card Fail. 2012;18:534–40. doi: 10.1016/j.cardfail.2012.05.003. - DOI - PMC - PubMed
    1. Khayat R, Jarjoura D, Porter K et al. Sleep disordered breathing and post-discharge mortality in patients with acute heart failure. Eur Heart J. 2015;36:1463–9. doi: 10.1093/eurheartj/ehu522. - DOI - PMC - PubMed
    1. Costanzo MR, Khayat R, Ponikowski P et al. Mechanisms and clinical consequences of untreated central sleep apnea in heart failure. J Am Coll Cardiol. 2015;65:72–84. doi: 10.1016/j.jacc.2014.10.025. - DOI - PMC - PubMed
    1. Bradley TD, Logan AG, Kimoff RJ et al. CANPAP Investigators. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med. 2005;353:2025–33. doi: 10.1056/NEJMoa051001. - DOI - PubMed